Other equities analysts also recently issued research reports about the company. TheStreet upgraded Itron from a “c+” rating to a “b-” rating in a report on Friday, August 16th. Credit Suisse Group lowered shares of Itron to an “outperform” rating in a research note on Tuesday, August 20th. BidaskClub upgraded shares of Itron from a “hold” rating to a “buy” rating in a research note on Wednesday, September 4th. Zacks Investment Research upgraded shares of Itron from a “hold” rating to a “buy” rating and set a $67.00 price target for the company in a research note on Monday, May 13th. Finally, Stephens began coverage on shares of Itron in a research note on Monday, July 8th. They issued an “equal weight” rating and a $64.00 price target for the company. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $69.00.
Shares of NASDAQ:ITRI traded down $1.11 during trading on Tuesday, hitting $72.94. The stock had a trading volume of 11,067 shares, compared to its average volume of 317,333. Itron has a 12 month low of $44.35 and a 12 month high of $74.12. The company has a market capitalization of $2.87 billion, a PE ratio of 27.55, a PEG ratio of 1.00 and a beta of 1.09. The firm’s fifty day moving average is $66.98 and its 200 day moving average is $58.24. The company has a quick ratio of 1.09, a current ratio of 1.44 and a debt-to-equity ratio of 1.39.
Itron (NASDAQ:ITRI) last announced its earnings results on Monday, August 5th. The scientific and technical instruments company reported $0.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.39. The firm had revenue of $635.04 million during the quarter, compared to analyst estimates of $598.59 million. Itron had a return on equity of 19.51% and a net margin of 2.52%. The business’s revenue was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.51 EPS. Equities research analysts expect that Itron will post 2.91 EPS for the current fiscal year.
In other Itron news, SVP Michel Cadieux sold 34,683 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $71.13, for a total transaction of $2,467,001.79. Following the completion of the sale, the senior vice president now directly owns 49,702 shares in the company, valued at approximately $3,535,303.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Philip Mezey sold 31,414 shares of the firm’s stock in a transaction dated Monday, July 1st. The shares were sold at an average price of $62.98, for a total transaction of $1,978,453.72. Following the sale, the insider now owns 74,624 shares of the company’s stock, valued at $4,699,819.52. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 69,433 shares of company stock valued at $4,665,468. 2.35% of the stock is owned by corporate insiders.
Large investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC increased its position in shares of Itron by 9.5% during the fourth quarter. Geode Capital Management LLC now owns 390,825 shares of the scientific and technical instruments company’s stock valued at $18,482,000 after acquiring an additional 33,782 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in shares of Itron by 47.7% in the first quarter. Oppenheimer Asset Management Inc. now owns 1,381 shares of the scientific and technical instruments company’s stock worth $64,000 after acquiring an additional 446 shares during the period. BNP Paribas Arbitrage SA grew its position in Itron by 336.1% during the first quarter. BNP Paribas Arbitrage SA now owns 8,390 shares of the scientific and technical instruments company’s stock valued at $391,000 after buying an additional 6,466 shares during the period. SG Americas Securities LLC bought a new stake in shares of Itron during the 1st quarter valued at $400,000. Finally, Rhumbline Advisers grew its holdings in Itron by 0.7% during the first quarter. Rhumbline Advisers now owns 95,354 shares of the scientific and technical instruments company’s stock valued at $4,448,000 after purchasing an additional 665 shares during the period. Institutional investors and hedge funds own 94.82% of the company’s stock.
Itron Company Profile
Itron, Inc, a technology and service company, provides end-to-end solutions that measures, manages, and analyzes energy and water use worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.
Featured Story: CBOE Russell 2000® Volatility Index
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.